MAP1LC3A Antikörper (C-Term)

Produktnummer ABIN388474

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch MAP1LC3A in WB und IHC (p). Es zeigt Reaktivität gegenüber Proben von Human. Es wurde in 12+ Publikationen zitiert.

Kurzübersicht für MAP1LC3A Antikörper (C-Term) (ABIN388474)

Target: MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MAP1LC3A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon: RB7485

Produktdetails anti-MAP1LC3A Antikörper

Bindungsspezifität: AA 77-106, C-Term

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This LC3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 77-106 amino acids from the C-terminal region of human LC3.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000. IHC-P: 1:50~100. IHC-P: 1:50~100

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Haltbarkeit: 6 months

Referenzen für anti-MAP1LC3A Antikörper (ABIN388474)

Eng, Panas, Karlsson Hedestam, McInerney: "A novel quantitative flow cytometry-based assay for autophagy." in: Autophagy, Vol. 6, Issue 5, pp. 634-41, (2012) (PubMed).

Ryu, Kim, Yeo, Kang: "p65/RelA-Ser529 NF-?B subunit phosphorylation induces autophagic astroglial death (Clasmatodendrosis) following status epilepticus." in: Cellular and molecular neurobiology, Vol. 31, Issue 7, pp. 1071-8, (2011) (PubMed).

Li, Wang, Fei, Xia, Qin, Liang: "Parkinson's disease involves autophagy and abnormal distribution of cathepsin L." in: Neuroscience letters, Vol. 489, Issue 1, pp. 62-7, (2011) (PubMed).

Zhuang, Li, Long, Chen, Huang, Liang: "Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy." in: Brain research, Vol. 1371, pp. 7-15, (2011) (PubMed).

Bartlett, Isakson, Lewerenz, Sanchez, Kotzebue, Cumming, Harris, Nezis, Schubert, Simonsen, Finley: "p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects." in: Autophagy, Vol. 7, Issue 6, pp. 572-83, (2011) (PubMed).

Arnold, Cassady, VanLaar, Berman: "Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model." in: Neurobiology of disease, Vol. 41, Issue 1, pp. 189-200, (2010) (PubMed).

Calakos, Patel, Gottron, Wang, Tran-Viet, Brewington, Beyer, Steffens, Krishnan, Züchner: "Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia." in: Journal of medical genetics, Vol. 47, Issue 9, pp. 646-50, (2010) (PubMed).

Cherra, Kulich, Uechi, Balasubramani, Mountzouris, Day, Chu: "Regulation of the autophagy protein LC3 by phosphorylation." in: The Journal of cell biology, Vol. 190, Issue 4, pp. 533-9, (2010) (PubMed).

Yang, Liu, Goga, Kim, Yuneva, Bishop: "Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 31, pp. 13836-41, (2010) (PubMed).

Wang, Gorvel, Chu, Wu, Lei: "Helicobacter pylori impairs murine dendritic cell responses to infection." in: PLoS ONE, Vol. 5, Issue 5, pp. e10844, (2010) (PubMed).

Caramés, Taniguchi, Otsuki, Blanco, Lotz: "Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis." in: Arthritis and rheumatism, Vol. 62, Issue 3, pp. 791-801, (2010) (PubMed).

Ren, He, Nong, Zhu, Hu, Zhang, Huang, Zhu, Wu: "Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy." in: Cancer biotherapy & radiopharmaceuticals, Vol. 25, Issue 1, pp. 75-80, (2010) (PubMed).

Details zu MAP1LC3A

Target: MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))

Andere Bezeichnung: LC3

Hintergrund: Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole). MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. These proteins are involved in formation of autophagosomal vacuoles (autophagosomes). MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. MAP1LC3b is one of the light chain subunits and can associate with either MAP1A or MAP1B. The precursor molecule is cleaved by APG4B/ATG4B to form the cytosolic form, LC3-I. This is activated by APG7L/ATG7, transferred to ATG3 and conjugated to phospholipid to form the membrane-bound form, LC3-II.

Molekulargewicht: 14688

Gen-ID: 81631

NCBI Accession: NP_073729

UniProt: Q9GZQ8

Pathways: Autophagie